News Search Results
Feb 13, 2024, 08:00 ET Ace Vision Group Names Val Kolesnitchenko, MD as Chief Scientific Officer
Dr. Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye BOSTON, Feb. 13, 2024
More news about: Ace Vision
Feb 13, 2024, 07:30 ET Foundation Fighting Blindness Hosting Webinar for Eye Care Professionals: Best Clinical Practices for Patients with Inherited Retinal Diseases
bit.ly/3RSWc3H The course will be delivered by: Rachel Huckfeldt, MD, PhD, is an assistant professor of Ophthalmology at Harvard Medical School and a clinician-scientist at Massachusetts Eye and Ear. She completed her MD and PhD training
More news about: Foundation Fighting Blindness
Feb 13, 2024, 07:00 ET InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
More news about: InMode LTD
Feb 13, 2024, 05:30 ET United States Ambulatory Surgical Centers Markets, 2023 and 2024-2029 - Reimbursement Schemes and Telehealth Drive Rapid Expansion
hospitals. The number of people suffering from gastroenterology disorders is increasing in the US and will increase further. In 2019, the number of ophthalmology ASCs in the US was less than 100; in 2022, it has increased to more than 1,000. This segment is still growing faster in the market, and the number
More news about: Research and Markets
Feb 08, 2024, 11:18 ET Renowned Ophthalmologist Dr. Wes Heroman Launches Prestigious Scholarship to Support Future Healthcare Leaders Nationwide
background and a commitment to excellence, Dr. Wes Heroman has dedicated his career to advancing the practice of Ophthalmology and mentoring future healthcare professionals. Contact Info: Spokesperson:
More news about: Dr Wes Heroman Scholarship
Feb 08, 2024, 07:00 ET Beacon Therapeutics Announces Positive 12-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis Pigmentosa
Pennesi, M.D., Ph.D., FARVO, Director, Ophthalmic Genetics at the Retina Foundation in Dallas, Texas; Professor of Ophthalmology and Professor of Molecular and Medical Genetics, Paul H. Casey Ophthalmic Genetics Division at the Casey Eye Institute, Oregon Health and Science
More news about: Beacon Therapeutics
Feb 07, 2024, 20:12 ET Energy-Based Aesthetic Devices Market to grow by USD 1.75 billion from 2022 to 2027, Alma Lasers GmbH, Bausch Health Co Inc., and Candela Corp are key Companies -Technavio
pain, shorter hospital stays, faster recovery, and cost savings over traditional surgeries. Non-invasive laser procedures are used in dermatology, ophthalmology, cardiovascular, cosmetic surgery, dentistry, and oncology. Rising disposable income boosts consumer purchasing power and device demand.
More news about: Technavio
Feb 07, 2024, 15:48 ET Optometry Software Market in Europe to grow by USD 291.95 million from 2022-2027; Hospitals segment to contribute significantly to market growth- Technavio
Growing ophthalmology marketIncreasing prevalence of eye disordersBenefits associated with optometry softwareThe growing ophthalmology market drives market growth. Eye diseases and technological advancements in the field of ophthalmology have been witnessing
More news about: Technavio
Feb 07, 2024, 09:26 ET Sectra continues its winning streak of global customer satisfaction with 5 Best in KLAS awards in 2024
radiology module is an integral part of Sectra's enterprise imaging solution, also comprising VNA and imaging modules for cardiology, orthopedics, ophthalmology, and digital pathology in one single system. Adam Gale, CEO of KLAS shared his thoughts for the 2024 winners:"At
More news about: Sectra
Feb 07, 2024, 09:00 ET SECTRA CONTINUES ITS WINNING STREAK OF GLOBAL CUSTOMER SATISFACTION WITH 5 BEST IN KLAS AWARDS IN 2024
radiology module is an integral part of Sectra's enterprise imaging solution, also comprising VNA and imaging modules for cardiology, orthopedics, ophthalmology, and digital pathology in one single system. Adam Gale, CEO of KLAS shared his thoughts for the 2024 winners:
More news about: Sectra, Inc
Feb 07, 2024, 03:35 ET Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, announces that the New Drug Application (NDA) for mazdutide (Innovent R&D code: IBI362), a glucagon-like peptide-1
More news about: Innovent Biologics
Feb 06, 2024, 20:30 ET Global Collagen Market Forecast to 2030: Growth in Application of Collagen in Medical and Pharmaceutical Industries
fundamental in modern medical practices. This segment is expected to experience rapid growth due to its indispensable role in bone reconstruction, ophthalmology, and wound care. The gelatin market is anticipated to seize a commanding market position, riding the wave of consumer preference for functionally
More news about: Research and Markets
Feb 06, 2024, 07:30 ET Foundation Fighting Blindness Launches GYROS, a Natural History Study for People with Gyrate Atrophy
investigators for the study are Mandeep S. Singh, MD, PhD, the Andreas C. Dracopoulos Professor of Ophthalmology and Associate Professor of Ophthalmology and Genetic Medicine at the Wilmer Eye Institute and David Valle, MD, Professor of Genetic Medicine
More news about: Foundation Fighting Blindness
Feb 05, 2024, 03:41 ET Innovent Announces Retirement of CFO and Appointment of New CFO
biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, announced that Mr. Ronald Hao Xi Ede will retire from his position as the chief financial
More news about: Innovent Biologics
Feb 05, 2024, 01:24 ET Ophthalmology Devices Market to Grow by USD 19.93 billion from 2022 to 2027: North America to contribute 41% - Technavio
covered in this Ophthalmology Devices Market report? CAGR during the forecast periodDetailed information on factors that will drive the growth of the Ophthalmology Devices Market between 2023 and 2027Precise estimation of the Ophthalmology Devices Market size
More news about: Technavio
Feb 02, 2024, 08:45 ET Mallinckrodt Announces Board of Directors and Leadership Updates
segments' areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; and gastrointestinal products. Its Specialty Generics
More news about: Mallinckrodt plc
Feb 01, 2024, 18:15 ET Global Hyaluronic Acid Raw Material Market Forecast Report 2024-2034, Featuring Zimmer Biomet, Sanof,i AbbVie, Anika Therapeutics, Lifecore Biomedical, Salix Pharmaceuticals & LG Chem
Grade: Orthopedic, Cosmetic, PharmaceuticalApplication: Drug Delivery, Surgical Adhesion Prevention, Orthopedics, Ophthalmology, DermatologyEnd-user: Cosmetic Clinics, Hospitals, OthersRegion: North America, Europe,
More news about: Research and Markets
Feb 01, 2024, 17:45 ET Texas Children's Hospital North Austin Campus Set to Open State-of-the-Art Facility
services, as well as various clinical subspecialties such as allergy and immunology, cardiology, clinical nutrition, diabetes and endocrinology, ophthalmology, plastic surgery, and pulmonology. Texas Children's has been building a presence in Austin, with more than
More news about: Texas Children's Hospital
Feb 01, 2024, 14:08 ET Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments
of many ophthalmic medications and devices used today. Dr. Luchs is Board Certified by the American Board of Ophthalmology, and a Fellow of the American Academy of Ophthalmology, the American College of Surgeons, and the American Society of Cataract and refractive Surgery (ASCRS). He is also a
More news about: Stuart Therapeutics
Feb 01, 2024, 12:53 ET Unifeye Vision Partners Expands in Ventura County
providers in targeted markets throughout the United States. The company provides management and support services to ophthalmology and optometry practices, as well as single-specialty eye surgery centers. UVP extends its operations to a network of 156 providers, 70 clinic locations,
More news about: Unifeye Vision Partners Management, LLC
Feb 01, 2024, 10:30 ET Medical Lasers Market Worth $8.3 Billion | MarketsandMarkets™
Based on application, the medical lasers market is segmented into aesthetic/cosmetic applications, dermatology applications, urology applications, ophthalmology applications, dental applications, ob/gyn applications, oncology applications, cardiovascular applications, and other applications. aesthetic/cosmetic
More news about: MarketsandMarkets
Feb 01, 2024, 09:00 ET Carl Zeiss Meditec AG Reaches Favorable Legal Settlement with Topcon
Landmark legal settlement protects customers, patients and the company's extensive digital innovation in ophthalmology The settlement includes undisclosed financial payment to Carl Zeiss Meditec as well as other penalties for Topcon's role in trade secret theft and misappropriation
More news about: Carl Zeiss Meditec AG
Jan 30, 2024, 14:07 ET Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
(formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and PPL, has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.
More news about: Piramal Pharma Ltd
Jan 30, 2024, 14:02 ET Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
(formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and PPL, has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a 20% strategic growth investment from the Carlyle Group.
More news about: Piramal Pharma Ltd
Jan 30, 2024, 11:15 ET NYU Langone Officially Opens State-of-the-Art Ambulatory Care Center in Former Garden City Bloomingdale's Building, its Largest on Long Island
NYU Langone Ambulatory Care Garden City includes 260 patient exam rooms and a new, expanded adult ophthalmology service. "NYU Langone is deeply committed to Long Island and expanding our vast network of clinicians
More news about: NYU Langone Health